Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
- Conditions
- Coronary Artery DiseasePlaque, Atherosclerotic
- Registration Number
- NCT06025305
- Lead Sponsor
- Jinling Hospital, China
- Brief Summary
The goal of this observational study is to develop an automatic whole-process AI model to detect, quantify, and characterize plaques using coronary CT angiography in coronary artery disease patients. The main questions it aims to answer are:
1. Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers;
2. Whether the AI model enables to identify vulnerable plaques using intravascular ultrasound or optical coherence tomography as the reference standard.
3. Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive CAD.
- Detailed Description
Coronary artery disease (CAD) remains the leading cause of death worldwide. Atherosclerotic plaques play a pivotal role in CAD-related patient mortality. Thus, the detection, quantification, and characterization of coronary plaques are clinically significant for early prevention and interventions for CAD.
Coronary CT angiography (CCTA) has emerged as a robust noninvasive tool for the evaluation of CAD. In clinical practice, the coronary plaque assessment is performed by a time-consuming manual process dependent on the clinician's experience and subjective visual interpretation. With the development of artificial intelligence, many automatic computer-aided methods have been proposed to post-process the CCTA images. However, previously proposed algorithms of plaque evaluation were not developed based on intravascular ultrasound (IVUS) or optical coherence tomography (OCT), which were regarded as the gold reference for plaque evaluation. Thus, we aimed to develop a deep learning model in a whole-process automatic and intelligent system on CCTA to detect, quantify, and characterize plaques using IVUS or OCT as reference standard. Then we will work on the validation in different clinical scenarios: (1) Validation of the accuracy of the new deep learning model; (2) Prognosis of the model in different populations with CAD.
The main questions it aims to answer are:
1. Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers;
2. Whether the AI model enables to identify vulnerable plaques using IVUS or OCT as the reference standard.
3. Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive coronary artery disease (China CT-FFR study 2).
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 2000
- Intravascular imaging (including intravascular ultrasound or optical coherence tomography) was performed within 3 months after CCTA;
- No change in medications or clinical symptoms during CCTA and intravascular imaging examinations;
- Coronary artery diameter stenosis of 30% to 90% on invasive coronary imaging.
- Image quality of CCTA or intravascular US was inadequate to analyze;
- Intravascular imaging was performed after percutaneous coronary intervention (PCI) or pre-dilation of the target lesions;
- Lesions could not be co-registered between CCTA and intravascular US;
- Missing CCTA or intravascular US data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of AI-assisted coronary CT angiography on identifying vulnerable plaques compared to intravascular imaging 1 day
- Secondary Outcome Measures
Name Time Method minimum lumen area measurement compared to intravascular ultrasound 1 day Total plaque volume 1 day Overall coronary plaque detection rate using intravascular ultrasound as reference standard 1 day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Research Institute Of Medical Imaging Jinling Hospital
🇨🇳Nanjing, Jiangsu, China
Research Institute Of Medical Imaging Jinling Hospital🇨🇳Nanjing, Jiangsu, China